- Home
- SO vs BMY Comparison
SO vs BMY Comparison
Compare SO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SO | BMY |
|---|---|---|
| Founded | 1945 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1B | 113.5B |
| IPO Year | 2011 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SO | BMY |
|---|---|---|
| Price | $93.10 | $61.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 23 | 28 |
| Target Price | ★ $96.29 | $65.63 |
| AVG Volume (30 Days) | 5.2M | ★ 11.8M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | 3.24% | ★ 4.00% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | 1.20 | ★ 2.93 |
| Revenue | $29,553,000,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $4.62 | $3.50 |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $78.05 | ★ $21.49 |
| Revenue Growth | ★ 10.59 | N/A |
| 52 Week Low | $81.69 | $42.52 |
| 52 Week High | $99.58 | $68.64 |
Technical Indicators
Market Signals| Indicator | SO | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 67.98 | 51.82 |
| Support Level | $92.15 | $59.91 |
| Resistance Level | $94.21 | $62.77 |
| Average True Range (ATR) | 1.56 | 1.81 |
| MACD | 0.91 | 0.50 |
| Stochastic Oscillator | 90.45 | 75.07 |
Price Performance
Historical ComparisonAbout SO Southern Company (The)
Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 46 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.